Year: 2000
Type: article
Study design: Systematic Review
Abstract: BACKGROUND: Double-blind placebo-controlled trials are the academic standard for clinical psychopharmacology research. AIMS: To identify the potential defects of current double-blind procedures in trials involving antidepressants and to investigate whether safeguards for blindness protection are used. METHOD: We reviewed the literature and devised a short seven-item checklist for evaluating the quality of blindness protection. We performed a computerised search for 1998 to identify the placebo-controlled studies that evaluated the efficacy of an antidepressant. The checklist was used to assess all traceable antidepressant trials published in 1998. RESULTS: Relevant criticisms question the blindness procedures. The available methods which may bolster blindness are very seldom used. CONCLUSIONS: Improvement in the blindness procedures used for antidepressant trials is necessary, feasible and measurable.
DOI: 10.1192/bjp.177.1.47
Authors: C. Even, E. Siobud-Dorocant, R. M. Dardennes
Institution: Centre Hospitalier Sainte-Anne
Language: English
Subfield: Statistics and Probability
Field: Mathematics
Domain: Physical Sciences
Open Access status: bronze
OpenAlex ID: W2156391328
